Neuroplast
Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.
Neuroplast has raised €14M across 2 funding rounds from 4 investors, most recently a Series B round in Nov 2021. Based in Geleen, Netherlands; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€14M
€14,000,000
Funding rounds
2
Investors
4
distinct backers
Active since
2020-02
latest 2021-11
Funding by year
EUR raised per yearNeuroplast — funding by year — interactive chart.
Data table
| Neuroplast — funding by year | |
|---|---|
| 2020 | €4.0M |
| 2021 | €10M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-18 | Series B | €10M | Brightlands Venture Partners,Lumana Invest,Netherlands Enterprise Agency,NV Industriebank LIOF | View deal → |
| 2020-02-19 | Other | €4.0M | — | View deal → |
Investors
4Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData